Lifebank Corp.
TSX VENTURE : LBK

Lifebank Corp.

January 10, 2008 17:44 ET

Lifebank Stock Options

BURNABY, BRITISH COLUMBIA--(Marketwire - Jan. 10, 2008) - As previously announced on January 8, 2008, Lifebank Corp. (the "Company") (TSX VENTURE:LBK) granted incentive stock options to purchase up to 575,000 Common shares in the capital of the Company at a price of $0.20 per share until January 8, 2013. The optionees included directors, officers, employees and consultants.

Ernest Stacey, President of the Company of 13589 25th Avenue, Surrey, BC V4P 1Z7 received 150,000 of the options, which together with 150,000 previously granted options, represent approximately 3% of the issued and outstanding shares of the Company (assuming exercise of the options and that no other Common shares of the Company are issued).

After giving effect to the acquisitions referred to above, Mr. Stacey beneficially owns 2,112,004 Common shares and options to purchase in aggregate 300,000 Common shares, which if no other outstanding convertible securities of the Company were converted, would represent approximately 24.1% of the issued and outstanding Common shares of the Company (assuming exercise of Mr. Stacey's options).

Mr. Stacey may, depending on market and other conditions, increase or decrease his beneficial ownership, control or direction over common shares or other securities of the Company through market transactions, private agreements, treasury purchases, exercise of convertible securities or otherwise.

Mr. Stacey will file a report describing the above transactions with applicable securities regulators, a copy of which will be available from Lifebank at 604-738-2722 and under Lifebank's profile at www.SEDAR.com.

Lifebank is a biomedical service company that provides processing and cryogenic (ultra low temperature) storage of umbilical cord blood stem cells. It is an AABB accredited, Health Canada inspected and FDA registered facility. Lifebank has successfully stored stem cell samples for clients in Canada, the United States, Europe, Asia, the Middle East and the Caribbean. Lifebank is dedicated to providing its clients with the finest cord blood stem cell processing, analysis and cryogenic storage services available in the world. Lifebank strives to work closely with physicians and public institutions in order to provide life saving cord blood services to any and all persons in need.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information